mots c and bpc 157 Peptides in Longevity Medicine: BPC-157, TB-500 & More mots c and bpc 157

HGF, hepatocyte growth factor

Transitioning from weight loss to maintenance Determining goal weight achievement: Lost 10-12% body weight (cagrilintide alone) Lost 15-25% body weight (CagriSema) Weight stable for 4-8 weeks Satisfied with current weight Ready to focus on maintenance Maintenance dose options comparison: Option 1: Continue same dose Keep cagrilintide at 2.4mg weekly Ensures no regain Most conservative approach Highest cost Option 2: Reduce dose slightly Decrease to 1.8-2.0mg weekly Monitor weight for 4 weeks If stable, maintain If gaining, increase back 20-25% cost savings Option 3: Try every 10 days Instead of weekly, inject every 10 days Effectively 30% dose reduction Some maintain weight this way Requires close monitoring Recommendation: Try Option 2 first (reduce to 1.8-2.0mg)

They can be injected in the same session (separately drawn up, separate syringes), but never mix in the same vial

Certificate of Analysis: Essential Verification for Researchers The COA is the single most important document for evaluating any BPC-157 research material

Irregularities and contamination are common